Skip to main content
SpringerLink
Log in

Type 1 diabetes

  • From the Analyst's Couch
  • Published:

From Nature Reviews Drug Discovery

View current issue Sign up to alerts

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figure 1: Diagnosed and drug-treated cases of type 1 diabetes (all age groups) in the major pharmaceutical markets by 2017.
Figure 2: Market for type 1 diabetes (T1D): 2007–2017.

References

  1. International Diabetes Federation. Diabetes Atlas 3rd edn (IDF, Brussels, 2007).

  2. Dabelea, D. The accelerating epidemic of childhood diabetes. Lancet 373, 1999–2000 (2009).

    Article  Google Scholar 

  3. Pittenger, G. L. et al. A role for islet neogenesis in curing diabetes. Diabetologia 52, 735–738 (2009).

    Article  CAS  Google Scholar 

  4. Suarez-Pinzon, W. L. et al. Combination therapy with glucagon-like peptide-1 and gastrin restores normoglycemia in diabetic NOD mice. Diabetes 57, 3281–3288 (2008).

    Article  CAS  Google Scholar 

  5. Suarez-Pinzon, W. L. et al. Combination therapy with a dipeptidyl peptidase-4 inhibitor and a proton pump inhibitor restores normoglycaemia in non-obese diabetic mice. Diabetologia 52, 1680–1682 (2009).

    Article  CAS  Google Scholar 

  6. Fleming, A. What will it take to get therapies approved for type 1 diabetes? Immunology of diabetes V. Ann. N.Y. Acad. Sci. 1150, 25–31 (2008).

    Article  Google Scholar 

  7. Ringholm Nielson, L. et al. Pregnancy-induced rise in serum C-peptide concentration in women with type 1 diabetes. Diabetes Care 32, 1052–1057 (2009).

    Article  Google Scholar 

  8. Gates, C., Wong, D. & Dreyfus, J. Type 1 Diabetes 1–147 (Decision Resources, Waltham, Massachusetts, 2008).

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Paul Burn is the Todd & Linda Broin Chair of the The Sanford Project at Sanford Health, Sanford School of Medicine of The University of South Dakota, 900 West Delaware Street, Sioux Falls, South Dakota 57104, USA. burnp@sanfordhealth.org,

    Paul Burn

Authors
  1. Paul Burn
    View author publications

    You can also search for this author in PubMed Google Scholar

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Burn, P. Type 1 diabetes. Nat Rev Drug Discov 9, 187–188 (2010). https://doi.org/10.1038/nrd3097

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrd3097

  • Springer Nature Limited

This article is cited by

Search

Navigation